Trials / Suspended
SuspendedNCT03467776
Bronchial Dilation Test in Wheezy Infants
Brochial Dilation Test by Salbutamol Metered Dose Inhaler(MDI) With Spacer in Wheezy Infants With Asthma Risk Factors
- Status
- Suspended
- Phase
- —
- Study type
- Observational
- Enrollment
- 90 (estimated)
- Sponsor
- Guangzhou Institute of Respiratory Disease · Academic / Other
- Sex
- All
- Age
- 5 Months – 36 Months
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to establish the methodology of bronchial dilation test by salbutamol MDI with Spacer in wheezy infants with asthma and to evaluate the effects of atopy on the exacerbation of wheeze in wheezy infants.
Detailed description
After screening,each participant undergo baseline pulmonary function test(Jaeger Master Screen Baby Body, Germany)and post-bronchodilator measurements that performed 10min after 200ug of salbutamol administered using a metered-dose inhaler and a spacer. The participants undergo baseline lung function test and bronchial dilation tests on the second and third visits with one-month interval,and whenever there is an exacerbation.
Conditions
Timeline
- Start date
- 2018-07-01
- Primary completion
- 2019-05-01
- Completion
- 2019-12-01
- First posted
- 2018-03-16
- Last updated
- 2018-03-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03467776. Inclusion in this directory is not an endorsement.